CZ20011627A3 - Nové kuličky s řízeným uvolňováním, způsob jejich přípravy a prostředek ve formě větąího počtu jednotek, který je obsahuje - Google Patents

Nové kuličky s řízeným uvolňováním, způsob jejich přípravy a prostředek ve formě větąího počtu jednotek, který je obsahuje

Info

Publication number
CZ20011627A3
CZ20011627A3 CZ20011627A CZ20011627A CZ20011627A3 CZ 20011627 A3 CZ20011627 A3 CZ 20011627A3 CZ 20011627 A CZ20011627 A CZ 20011627A CZ 20011627 A CZ20011627 A CZ 20011627A CZ 20011627 A3 CZ20011627 A3 CZ 20011627A3
Authority
CZ
Czechia
Prior art keywords
producing
same
controlled release
multiple unit
release beads
Prior art date
Application number
CZ20011627A
Other languages
English (en)
Other versions
CZ299582B6 (cs
Inventor
Torkel Gren
Anders Ringberg
Martin Wikberg
Randy J. Wald
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20413266&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CZ20011627(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from PCT/SE1999/001463 external-priority patent/WO2000012069A1/en
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Publication of CZ20011627A3 publication Critical patent/CZ20011627A3/cs
Publication of CZ299582B6 publication Critical patent/CZ299582B6/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
CZ20011627A 1998-11-11 1999-11-11 Nové kulicky s rízeným uvolnováním, zpusob jejichprípravy a prostredek ve forme vetšího poctu jednotek, který je obsahuje CZ299582B6 (cs)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9803871A SE9803871D0 (sv) 1998-11-11 1998-11-11 Therapeutic method and formulation
PCT/SE1999/001463 WO2000012069A1 (en) 1998-08-27 1999-08-26 Therapeutic formulation for administering tolterodine with controlled release

Publications (2)

Publication Number Publication Date
CZ20011627A3 true CZ20011627A3 (cs) 2001-10-17
CZ299582B6 CZ299582B6 (cs) 2008-09-10

Family

ID=20413266

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ20011627A CZ299582B6 (cs) 1998-11-11 1999-11-11 Nové kulicky s rízeným uvolnováním, zpusob jejichprípravy a prostredek ve forme vetšího poctu jednotek, který je obsahuje

Country Status (40)

Country Link
US (1) US6911217B1 (cs)
EP (1) EP1128819B1 (cs)
JP (1) JP3616011B2 (cs)
KR (1) KR100467384B1 (cs)
CN (1) CN1169522C (cs)
AP (1) AP1323A (cs)
AR (1) AR027815A1 (cs)
AT (1) ATE247458T1 (cs)
AU (1) AU762410B2 (cs)
BG (1) BG65149B1 (cs)
BR (1) BRPI9915142B8 (cs)
CA (1) CA2350061C (cs)
CZ (1) CZ299582B6 (cs)
DE (1) DE69910604T2 (cs)
DK (1) DK1128819T3 (cs)
EA (1) EA005074B1 (cs)
EE (1) EE05232B1 (cs)
ES (1) ES2204193T3 (cs)
GE (1) GEP20022833B (cs)
HK (1) HK1040917B (cs)
HR (1) HRP20010333B1 (cs)
HU (1) HU226582B1 (cs)
ID (1) ID30039A (cs)
IL (1) IL142809A0 (cs)
IS (1) IS2370B (cs)
MA (1) MA25325A1 (cs)
MY (1) MY122195A (cs)
NO (1) NO331399B1 (cs)
NZ (1) NZ511430A (cs)
OA (1) OA11673A (cs)
PL (1) PL195780B1 (cs)
PT (1) PT1128819E (cs)
RS (1) RS49891B (cs)
SE (1) SE9803871D0 (cs)
SI (1) SI1128819T1 (cs)
SK (1) SK284758B6 (cs)
TW (2) TWI222879B (cs)
UA (1) UA57165C2 (cs)
WO (1) WO2000027364A1 (cs)
ZA (1) ZA200103575B (cs)

Families Citing this family (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU728395B2 (en) * 1996-07-19 2001-01-11 Gunnar Aberg S(-)-tolterodine in the treatment of urinary and gastrointestinal disorders
US8563522B2 (en) 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
EP0957073A1 (en) 1998-05-12 1999-11-17 Schwarz Pharma Ag Novel derivatives of 3,3-diphenylpropylamines
CN100353935C (zh) * 1999-11-11 2007-12-12 法马西雅公司 含托特罗定的药物制剂及其应用
MXPA05002302A (es) * 2002-08-28 2005-06-08 Pharmacia Corp Composicion liquida oral de tolterodina.
US8168170B2 (en) 2002-10-03 2012-05-01 The Procter And Gamble Company Compositions having an inner core and at least three surrounding layers
MXPA05007767A (es) * 2003-01-22 2006-01-31 Pfizer Health Ab Dosis reducida de tolterodina y otros agentes antimuscarinicos para tratar trastornos urinarios.
DE10315917A1 (de) * 2003-04-08 2004-11-18 Schwarz Pharma Ag Hochreine Basen von 3,3-Diphenylpropylaminmonoestern
WO2004112756A1 (en) 2003-06-26 2004-12-29 Isa Odidi Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
ATE493981T1 (de) 2003-11-04 2011-01-15 Supernus Pharmaceuticals Inc Einmal tägliche dosierformen von trospium
US8709476B2 (en) 2003-11-04 2014-04-29 Supernus Pharmaceuticals, Inc. Compositions of quaternary ammonium compounds containing bioavailability enhancers
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US20050152884A1 (en) 2003-12-19 2005-07-14 The Procter & Gamble Company Canine probiotic Bifidobacteria globosum
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US7785635B1 (en) 2003-12-19 2010-08-31 The Procter & Gamble Company Methods of use of probiotic lactobacilli for companion animals
US8894991B2 (en) 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
US8394409B2 (en) * 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
EP1629834A1 (en) 2004-08-27 2006-03-01 KRKA, D.D., Novo Mesto Sustained release pharmaceutical composition of tolterodine
EP1836156A1 (en) * 2005-01-10 2007-09-26 Teva Gyogyszergyar Reszvenytarsasag Substantially pure tolterodine tartrate and process for preparing thereof
PL1885383T3 (pl) 2005-05-31 2017-06-30 Iams Europe B.V. Kocie probiotyczne bifidobakterie
WO2006130187A1 (en) 2005-05-31 2006-12-07 The Iams Company Feline probiotic lactobacilli
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
US8298574B2 (en) 2006-01-18 2012-10-30 Intec Pharma Ltd. Method and apparatus for forming delivery devices for oral intake of an agent
CA2882048C (en) 2006-02-03 2020-03-24 Proventiv Therapeutics, Llc Treating vitamin d insufficiency and deficiency with 25-hydroxyvitamin d2 and 25-hydroxyvitamin d3
KR100714058B1 (ko) * 2006-02-06 2007-05-02 한국유나이티드제약 주식회사 톨테로딘 엘-주석산염의 서방형 경구투여 조성물 및 이의 제조 방법
KR20080099334A (ko) * 2006-02-24 2008-11-12 테바 파마슈티컬 인더스트리즈 리미티드 메토프로롤 숙시네이트 서방정 및 이의 제조 방법
MX2008011952A (es) * 2006-03-21 2008-10-01 Teva Pharma Formulacion de liberacion controlad de tolterodina.
EP1839649A1 (en) * 2006-03-31 2007-10-03 LEK Pharmaceuticals D.D. Coated formulations for tolterodine
CN101453993A (zh) * 2006-04-03 2009-06-10 伊萨·奥迪迪 含有机溶胶涂层的受控释放递送物件
WO2007122015A1 (en) * 2006-04-21 2007-11-01 Synthon B.V. Tolterodine beads
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
EP2026766A1 (en) 2006-05-17 2009-02-25 Synthon B.V. Tablet composition with a prolonged release of tamsulosin
ES2497494T3 (es) 2006-06-21 2014-09-23 Opko Renal, Llc Método de tratamiento y prevención del hiperparatiroidismo secundario
JP2008007458A (ja) * 2006-06-29 2008-01-17 Freunt Ind Co Ltd レイヤリング用核粒子とその製造方法
MX2009005478A (es) 2006-11-27 2009-08-12 Lundbeck & Co As H Derivados de heteroarilamida.
JP5799299B2 (ja) 2007-02-01 2015-10-21 ザ・アイムス・カンパニーＴｈｅ Ｉａｍｓ Ｃｏｍｐａｎｙ ブドウ糖代謝拮抗物質、アボカド又はアボカド抽出物を使用する、哺乳動物における炎症及びストレスの低下方法
WO2008134523A1 (en) 2007-04-25 2008-11-06 Proventiv Therapeutics, Llc Method of safely and effectively treating and preventing secondary hyperparathyroidism in chronic kidney disease
KR20190028822A (ko) 2007-04-25 2019-03-19 사이토크로마 인코포레이티드 비타민 ｄ 화합물과 밀랍성 담체를 포함하는 경구 조절성 방출 조성물
WO2009047644A2 (en) 2007-04-25 2009-04-16 Cytochroma Inc. Method of treating vitamin d insufficiency and deficiency
US20090017111A1 (en) * 2007-07-03 2009-01-15 Van Den Heuvel Dennie J M Tolterodine bead
US8110226B2 (en) * 2007-07-20 2012-02-07 Mylan Pharmaceuticals Inc. Drug formulations having inert sealed cores
US8486452B2 (en) * 2007-07-20 2013-07-16 Mylan Pharmaceuticals Inc. Stabilized tolterodine tartrate formulations
US8871275B2 (en) 2007-08-08 2014-10-28 Inventia Healthcare Private Limited Extended release compositions comprising tolterodine
PL2187873T3 (pl) * 2007-08-13 2019-01-31 Abuse Deterrent Pharmaceutical Llc Leki odporne na nadużywanie, metoda stosowania i metoda wytwarzania
US20090192228A1 (en) * 2008-01-28 2009-07-30 Actavis Group Ptc Ehf Controlled-Release Tolterodine Compositions and Methods
US20090214665A1 (en) * 2008-02-26 2009-08-27 Lai Felix S Controlled Release Muscarinic Receptor Antagonist Formulation
CA2629099A1 (en) * 2008-04-01 2009-10-01 Pharmascience Inc. Novel oral controlled release pharmaceutical formulations
US8962239B2 (en) 2008-04-02 2015-02-24 Opko Renal, Llc Methods useful for vitamin D deficiency and related disorders
WO2009140557A2 (en) * 2008-05-14 2009-11-19 Capricorn Pharma, Inc. Modified release tolterodine formulations
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US8465770B2 (en) 2008-12-24 2013-06-18 Synthon Bv Low dose controlled release tablet
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
AU2010277207B2 (en) * 2009-07-31 2014-06-26 Sun Pharmaceutical Industries Limited Multi-layered, multiple unit pharmaceutical compositions
WO2011061616A2 (en) 2009-11-23 2011-05-26 Micro Labs Limited Extended release compositions containing tolterodine and process for preparing the same
WO2011095388A1 (en) 2010-02-04 2011-08-11 Synthon Bv Tolterodine bead
JO3112B1 (ar) 2010-03-29 2017-09-20 Ferring Bv تركيبة دوائية سريعة التحلل
JP5736031B2 (ja) 2010-03-29 2015-06-17 フェリング ベスローテン フェンノートシャップ 速溶解性医薬組成物
PT2552484T (pt) 2010-03-29 2020-04-03 Opko Ireland Global Holdings Ltd Métodos e composições para redução dos níveis de parafróides
US8748433B2 (en) 2010-04-30 2014-06-10 Merck Sharp & Dohme Corp. β3 adrenergic receptor agonists
US20120040008A1 (en) * 2010-08-11 2012-02-16 Ashish Chatterji Pharmaceutical compositions of metabotropic glutamate 5 receptor (mglu5) antagonists
US20120289560A1 (en) * 2011-05-10 2012-11-15 Theravida, Inc. Combinations of tolterodine and salivary stimulants for the treatment of overactive bladder
GR1007628B (el) 2011-07-27 2012-06-29 Φαρματεν Αβεε, Φαρμακευτικο σκευασμα περιεχον εναν αντιμουσκαρινικο παραγοντα και μεθοδος για την παρασκευη αυτου
AU2012307530B2 (en) 2011-09-16 2016-12-08 Ferring B.V. A fast dissolving pharmaceutical composition
WO2013047795A1 (ja) * 2011-09-30 2013-04-04 アステラス製薬株式会社 粒子状医薬組成物
AU2013289403B2 (en) 2012-07-12 2017-05-11 Ferring B.V. Diclofenac formulations
WO2014047477A2 (en) * 2012-09-20 2014-03-27 Sks Ocular, Llc Multilayer biodegradable microparticles for sustained release of therapeutic agents
TW201422254A (zh) 2012-11-21 2014-06-16 Ferring Bv 用於速釋及延釋的組成物
US20150306170A1 (en) * 2012-11-21 2015-10-29 Ferring B.V. Composition for immediate and extended release
WO2014159051A1 (en) * 2013-03-13 2014-10-02 Advanced Bionutrition Corp. Stable bioactive substances and methods of making
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 ｄ 방출 제형
US11571390B2 (en) 2013-03-15 2023-02-07 Othemo Life Sciences, Inc. Abuse deterrent compositions and methods of use
AU2014246617A1 (en) 2013-12-23 2015-07-09 Sun Pharmaceutical Industries Limited Multi-layered, multiple unit pharmaceutical compositions
EP3193925A2 (en) 2014-08-07 2017-07-26 OPKO Ireland Global Holdings, Ltd. Adjunctive therapy with 25-hydroxyvitamin d
US10729685B2 (en) 2014-09-15 2020-08-04 Ohemo Life Sciences Inc. Orally administrable compositions and methods of deterring abuse by intranasal administration
CA3018328A1 (en) * 2014-10-31 2016-04-30 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
EP3431107A4 (en) * 2016-02-23 2019-11-13 Nipro Corporation PARTICULARS OF A PHARMACEUTICAL COMPOSITION AND MOUTH-DISTURBING PREPARATION THEREOF
IL290855B1 (en) 2016-03-28 2024-02-01 Eirgen Pharma Ltd Treatment methods using vitamin D

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1144911B (it) * 1981-03-19 1986-10-29 Pharmatec Spa Composizione farmaceutica a rilascio controllato contenente ibuprofen
JPH07107450A (ja) 1993-10-08 1995-04-21 Hitachi Ltd 情報通信装置
JP3453186B2 (ja) 1994-04-14 2003-10-06 共和薬品工業株式会社 徐放性マイクロカプセルおよびその製造方法
SE9402422D0 (sv) * 1994-07-08 1994-07-08 Astra Ab New beads for controlled release and a pharmaceutical preparation containing the same
US5645858A (en) * 1994-10-06 1997-07-08 Ortho Pharmaceutical Corporation Multilayered controlled release pharmaceutical dosage form
US5567441A (en) * 1995-03-24 1996-10-22 Andrx Pharmaceuticals Inc. Diltiazem controlled release formulation
AU728395B2 (en) 1996-07-19 2001-01-11 Gunnar Aberg S(-)-tolterodine in the treatment of urinary and gastrointestinal disorders
US6312728B1 (en) * 1998-07-07 2001-11-06 Cascade Development, Inc. Sustained release pharmaceutical preparation

Also Published As

Publication number Publication date
TWI222879B (en) 2004-11-01
AP2001002166A0 (en) 2001-06-30
EA200100538A1 (ru) 2001-10-22
AR027815A1 (es) 2003-04-16
BRPI9915142B8 (pt) 2021-05-25
MA25325A1 (fr) 2001-12-31
DE69910604D1 (de) 2003-09-25
EE05232B1 (et) 2009-12-15
KR100467384B1 (ko) 2005-01-24
NZ511430A (en) 2003-05-30
DE69910604T2 (de) 2004-06-24
BR9915142A (pt) 2001-08-07
CA2350061A1 (en) 2000-05-18
OA11673A (en) 2005-01-12
HUP0105038A3 (en) 2006-07-28
EA005074B1 (ru) 2004-10-28
CZ299582B6 (cs) 2008-09-10
JP3616011B2 (ja) 2005-02-02
UA57165C2 (uk) 2003-06-16
NO331399B1 (no) 2011-12-19
AU1436600A (en) 2000-05-29
EP1128819B1 (en) 2003-08-20
IS5936A (is) 2001-05-09
DK1128819T3 (da) 2003-12-01
BRPI9915142B1 (pt) 2015-08-25
CN1169522C (zh) 2004-10-06
MY122195A (en) 2006-03-31
SI1128819T1 (en) 2003-12-31
WO2000027364A1 (en) 2000-05-18
TWI267385B (en) 2006-12-01
NO20012314L (no) 2001-07-09
SK284758B6 (sk) 2005-11-03
PL348612A1 (en) 2002-06-03
KR20010075695A (ko) 2001-08-09
SK6252001A3 (en) 2002-01-07
AP1323A (en) 2004-11-05
HK1040917A1 (en) 2002-06-28
EP1128819A1 (en) 2001-09-05
BG105582A (en) 2001-12-29
JP2003517446A (ja) 2003-05-27
PT1128819E (pt) 2003-12-31
HRP20010333A2 (en) 2003-04-30
NO20012314D0 (no) 2001-05-10
RS49891B (sr) 2008-08-07
ZA200103575B (en) 2002-05-03
HU226582B1 (en) 2009-04-28
ID30039A (id) 2001-11-01
IL142809A0 (en) 2002-03-10
AU762410B2 (en) 2003-06-26
HUP0105038A2 (en) 2002-06-29
HRP20010333B1 (en) 2004-10-31
EE200100254A (et) 2002-12-16
PL195780B1 (pl) 2007-10-31
CA2350061C (en) 2005-05-17
IS2370B (is) 2008-06-15
BG65149B1 (bg) 2007-04-30
HK1040917B (zh) 2005-05-27
YU33101A (sh) 2003-10-31
ES2204193T3 (es) 2004-04-16
ATE247458T1 (de) 2003-09-15
SE9803871D0 (sv) 1998-11-11
US6911217B1 (en) 2005-06-28
GEP20022833B (en) 2002-11-25
CN1326339A (zh) 2001-12-12

Similar Documents

Publication Publication Date Title
CZ20011627A3 (cs) Nové kuličky s řízeným uvolňováním, způsob jejich přípravy a prostředek ve formě větąího počtu jednotek, který je obsahuje
EP1054034A4 (en) EXPANDABLE MICROSPHERES AND THEIR PRODUCTION METHOD
AU1943699A (en) Patterned coated articles and methods for producing the same
HK1031382A1 (en) Spiroazabicyclic heterocyclic compounds, a method for producing the same and use thereof
AU1053199A (en) Exposure apparatus and method of manufacturing the same, and exposure method
AU2513195A (en) Superabsorbent foams, and method for producing the same
PL346343A1 (en) Micro-lasing beads and structures, and associated methods
HUP0101192A3 (en) Cycloalkene derivatives, process for producing the same, and use
AU3031899A (en) Nanoparticles, method for producing nanoparticles and use of the same
GB2336843B (en) Carboxyl-containing alicyclic compounds and a process for preparing the same
HU9802132D0 (en) Biphenyl-sulfonyl-cyanamides, process for producing them and their medical use
HK1029114A1 (en) Thiodepsipeptides for combating endoparasites and a method for producing the same
AU7809198A (en) Electoluminescent device and method for producing the same
AU5398298A (en) Neutral-tasting microcapsules, method for their manufacturing and their use
ZA973433B (en) A sertindole-containing preparation and a method for producing the same.
AU1691899A (en) Exposure apparatus, method of producing the apparatus, and exposure method, and device and method of manufacturing the device
HUP0004043A3 (en) Impregnated salts, a method for producing said salts, and the use of the same
AU5645598A (en) New benzoxazinedione derivatives, a method of producing them and the use thereof
AU6333199A (en) Webbing and method for producing the same
IL138904A0 (en) Magnetic- abrasive powder, and method of producing the same
AU1944799A (en) Hyperhydrated citicoline, process and use
AU2002221904A1 (en) Ceiling and method for producing the same
PL345537A1 (en) Plaster which contains steroids, and a method for the production and use thereof
AU2517999A (en) Self-supporting fusion-bonded film, method for producing said film and use of the same
AU7035998A (en) New thiazoledinediones, method for the production thereof, and medicaments containing the same

Legal Events

Date Code Title Description
MK4A Patent expired

Effective date: 20191111